MKL (MKL)

$23.6B
Market Cap
11.1
P/E Ratio
0.77
Beta
Dividend Yield
Piotroski 5/9Altman Z 1.0 DistressROIC−WACC -5.4%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 5/9, Altman Z 1.0.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of MKL present a mixed profile characterized by efficient capital deployment but declining revenue momentum. While the DuPont decomposition reveals that return on equity is driven primarily by high leverage (3.61x) rather than operational efficiency, with asset turnover sitting at just 0.24x and net margins holding steady at 12.9%, the ROIC of 3.4% suggests capital generation struggles to outpace required returns in a risk-adjusted context. This structural reliance on leverage is tempered by deteriorating top-line performance, evidenced by revenue contraction of -2.5% year-over-year, which aligns with a moderate Piotroski F-Score of 5/9 indicating average financial strength without recent significant improvement or deterioration signals.

Valuation metrics suggest the market may be pricing in a compressed growth outlook relative to historical norms and sector peers, given the current P/E multiple of 11.1x. However, this valuation appears disconnected from intrinsic value models; the DCF analysis implies a fair value of $3,395, which would necessitate substantial future earnings acceleration or margin expansion not currently reflected in the -2.5% revenue trajectory. The discrepancy between the low multiple and high implied fair value indicates that either the market is undervaluing long-term potential based on current depressed fundamentals or expects a significant re-rating of growth assumptions to justify such a premium.

Insider activity introduces a counterweight to the valuation divergence, with $207,948 in net selling over the last 90 days signaling caution from those closest to the business operations. This outflow contrasts sharply with the bullish implication of the DCF model and suggests insiders may be hedging against potential execution risks inherent in reversing negative revenue trends while managing a highly leveraged balance sheet. The convergence of shrinking revenues, low ROIC relative to leverage, and insider distribution creates an environment where future stock performance will depend heavily on whether operational improvements can materialize quickly enough to validate the elevated DCF-based pricing versus the more conservative multiple expansion needed to support current levels.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6.7%8.7%10.7%
2%$4260$2989$2300
3%$5215$3395$2516
4%$6869$3973$2796

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.7%, terminal growth 3%. Fair value $3395 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
1.0
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

12.9%
Net Margin
3.4%
ROIC
8.7%
WACC
ROIC − WACC Spread: -5.4%— Negative spread.
-2.5%
Revenue Growth (YoY)
-23.3%
Earnings Growth (YoY)
2.6B
Free Cash Flow
1%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

12.9%
Net Profit Margin
NI ÷ Revenue
×
0.24x
Asset Turnover
Revenue ÷ Assets
×
3.61x
Equity Multiplier
Assets ÷ Equity
=
11.0%
Return on Equity
⚠️ High equity multiplier — ROE is being amplified by leverage, not operational excellence.

Balance Sheet Health

2.61x
Debt / Equity
14.3x
Interest Coverage
0.1x
Net Debt / EBITDA
10.67%
FCF Yield
3.3B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-207,948
Net Selling
0
Buy Transactions
1
Sale Transactions
2026-02-26WILSON SIMONSold 2/8 qtrsSale$207,948
2026-02-24GAYNER THOMAS SINNICKSONGrant4,483 shares
2026-02-24GRINNAN RICHARD RANDOLPHGrant800 shares
2026-02-24COSTANZO BRIAN JGrant654 shares
2026-02-24CROWLEY ANDREW G.Grant830 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $17.97
Act: $23.64
+31.6%
Q3
✓ Beat
Est: $25.04
Act: $25.62
+2.3%
Q2
✓ Beat
Est: $23.77
Act: $31.61
+33.0%
Q1
✓ Beat
Est: $25.73
Act: $37.41
+45.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

14.8
Forward P/E
PEG Ratio
1.27
Price/Book
46667
Avg Volume
$2207.59
52W High
$1621.89
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.7B
Tracked Passive Exposure
8
ETFs Holding MKL
0.06%
Avg Weight in ETFs
$2.8T
Total ETF AUM

When investors buy or sell ETFs like KIE or VFMV, the fund manager is mechanically forced to buy or sell MKL shares regardless of MKL's individual fundamentals. We estimate $1.7B of passive capital is structurally linked to MKL through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in MKL to visualize passive redemption contagion across ETFs and collateral stocks.

MKL Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
MKLEpicenterVTIETFVTVETFVOETFJPMHigh RiskBRK.BUnknownMALow RiskBACHigh RiskVLow Risk
MKL Price Drop (%)0

If MKL (MKL) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies JPMorgan Chase & Co. (JPM) as the most exposed collateral stock, sharing 2 ETFs with MKL. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 16 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

MKL Ownership Dynamics

Ticker
MKL

Float lock-up computed from 16 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

MKL Capital Efficiency

How efficiently does MKL convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$2.6B
EBITDA
$3.3B
FCF Conversion
78%
Reinvestment Rate
22%
78% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
3.4%
ROIC − WACC Spread
-5.4%

MKL converts 78% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-5.4%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-04-288$1895.74$15,165.92
2026-04-0745$1907.31$85,828.95
2026-03-302,021$1867.29$3.8M
2026-03-266$1892.82$11,356.92
2026-03-19589$1914.15$1.1M
2026-03-162,070$1942.78$4.0M
2026-03-059$2040.25$18,362.25
2026-03-02255$2072.47$528,479.85
2026-02-191$2071.16$2,071.16
2026-02-1213$2099.06$27,287.78
2026-02-049$2038.65$18,347.85
2026-01-05439$2130.36$935,228.04
2025-11-1346$2091.91$96,227.86
2025-11-12274$2061.19$564,766.06
2025-10-311,023$1938.38$2.0M
2025-10-241$1896.18$1,896.18
2025-10-221$1905.26$1,905.26
2025-10-16173$1916.48$331,551.04

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare MKL to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.